Journal of Addiction Research & Therapy
Open Access

Abstract

Problem: Global pandemics COVID-19, Bird Flu, Hay fever, Swine Flu, HIV, Respiratory, Cancer & chronic immunity disorders. People with weak immunity are at higher risk of getting these infections with increased morbidity. Solution: Our Nano-biotech product made from colostrum nano informational peptides helps people lead longer & healthier lives by naturally building the body’s own immune system, aiding in prevention & cure of all communicable & immunity diseases for bottom of the pyramid segment globally. The biggest thing in today’s healthcare is the smallest Nano peptides of REEPTOL capable of preventing global pandemics. Innovation Journey: After 18 years of research, we have successfully isolated Nano peptides from bovine colostrum and conducted global clinical studies on subjects suffering from AIDS, Swine Flu, other communicable & Immunity diseases. RECEPTOL® manufactured by Biomix was discovered by Dr. Pawan Saharan, MS, Ph.D. WVU, Stanford with eminent group of scientists including 2 times Nobel laureate Prof. George Wald from Harvard & Prof. Joseph Weizenbaum, MIT Founder Directors with 18 years of research and development with funding by the Department of Science & Technology, GoI. Product: RECEPTOL®, made from Colostrum Nano-peptides helps people lead longer & healthier lives by building the body’s immune system, thus aiding in prevention as vaccine by activating memory cells and possible cure of communicable & Immunity diseases: Covid, AIDS, Swine Flu, Asthma, Allergy, Arthritis, Diabetes Type 2, several unmet need in oncology Receptol®️ showed great effectiveness in treatment of retrovirus such as HIV, Swine Flu and SARS like conditions caused by Coronavirus. An accelerated, prospective Phase III global efficacy and safety studies for Receptol®️ Monotherapy was conducted for HIV Positive patients with 13 years follow as therapy & vaccine showed significant resolution of all symptoms within 3 weeks including consistent week after week weight gain and pharmacological effects with low to undetectable Viral Load and increased Absolute CD4 Counts. Active Ingredients (API) - Active Ingredients consist of Patented Nano-Informational Peptides extracted from mammalian/ bovine colostrum via Ultra Nano filtration Technology having sequence id 1-8 & Proline Rich Poly Peptides (PRPs) with no side effects & can be taken safely by all age groups from neonates to geriatric population. Mode of Action: Receptol® gets absorbed in the blood through the buccal mucosa and crosses the Blood-Brain-Barrier stimulating maturation of immature thymocytes into helper or suppressor T cells. It also stimulates secretion of Tumour Necrosis Factor, IL-1 to IL-11, INF-a, INF-y. Activates Natural Killer (NK) Cells, cytotoxic cells of the innate immune system by 5X times. Receptol®️ oral spray can be an answer to prevent & treat current majority of Communicable IDs Respiratory, Endometriosis, Cancer & Neural disorders viz Alzimer, Parkinson & Dementia per granted therapeutic Product Patents from US, UK, Across EU & India based on its Mode of Action with global clinical Phase 1-4 studies with 13 years follow up with 100% efficacy & safety conducted on standalone mono-therapy. In case of HIV & SARS Covid Receptol®️’s nano-peptide not only dock on cell surface glycopeptide receptors of CD4, CD8, Epithelial cells, S glycoprotein receptor on the cell surface to mitigate cell fusion though competitive inhibition, closing doors and windows for all viral RNA entry but will also stimulate the maturation of immature thymocytes into helper & suppresser T cells. T helper cells will help produce antibodies & deactivate other lymphocytes after an infection has been cleared to avoid damage to healthy tissues. Receptol®️activate memory T cells, in order to expedite the production of antibodies for future infection in all human hosts as a broad spectrum vaccine.

Biography

Saharan holds a Ph.D. Major in Medicine from West Virginia Medical Center, USA and topped First Rate Jawaharlal Nehru University in New Delhi while pursuing a Master in Life Sciences. He has authored several international publications and presentations, including the leading scientific journal, Nature. He has organized several global conferences and led the Global Impact of Nano biotechnology in Healthcare.